NEW YORK, Dec. 10, 2024 /PRNewswire/ — Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has launched their “all-in-one” contract research organization (CRO), site, and technology offering bespoke to the unique needs of…
Coronary/Structural Heart
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care
– Collaboration combines Terumo’s ePRISM™ precision medicine software platform with Medis’ QFR® technology – SOMERSET, N.J., Dec. 10, 2024 /PRNewswire/ — Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging…
SUPIRA MEDICAL INITIATES U.S. EARLY FEASIBILITY STUDY (EFS) FOR HIGH-RISK PCI
Company expands clinical program beyond 70 patients already treated in South America FIH and Feasibility Studies. FDA acknowledged potential benefits of the Supira System by granting the company a review pathway under the Breakthrough Device Program. Results from EFS will be used to support submission to FDA for Supira’s pivotal […]
Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies
– Solid Biosciences to collaborate with Mayo Clinic’s genetic cardiology disease laboratory –
Two-Year Data Proves Vista Cardiac Delivers Faster, More Reliable MRI Scans
PALO ALTO, Calif.–(BUSINESS WIRE)–Vista, a leader in intelligent MRI acquisition software, today announced two-year clinical results showing Vista Cardiac significantly improves workflow efficiency, ensures high-quality and consistent imaging, and scales cardiac MRI (CMR) programs to expand access to more patients. “We’re pleased with the strong data from Brigham and Women’s Hospital validating […]
New Technology from Riverain Adds Coronary Artery Calcification Scoring to Ungated Chest CT Scans
Incidental CAC Scores Now Possible with ClearRead™ CT MIAMISBURG, Ohio, Dec. 3, 2024 /PRNewswire/ — Coronary artery calcification (CAC) affects 20 million Americans annually, and over half of the incidental findings go unreported.* New FDA-cleared technology from Riverain can provide a…
Press Release: Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update
Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update
Cleerly Makes Debut at RSNA 2024, Showcasing AI-Enabled Innovations in Cardiovascular Imaging
Join Cleerly Leadership for Live Demonstrations on Advanced Imaging Solutions for Personalized Heart Disease Care DENVER, Nov. 26, 2024 /PRNewswire/ — Cleerly, a leader in advanced cardiovascular imaging, is excited to announce its participation in the Radiological Society of North…
BrioHealth Solutions Begins Patient Enrollment in INNOVATE Trial of BrioVAD® System for Advanced Heart Failure
November 25, 2024 09:21 AM Eastern Standard Time BURLINGTON, Mass.–(BUSINESS WIRE)–BrioHealth Solutions, Inc., a developer of world-leading technology in ventricular assist systems, announced today it has enrolled its first patients in the U.S. for the INNOVATE Trial of the BrioVAD® System. BrioHealth Solutions announced today the first patients have been enrolled […]
Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies
DALLAS–(BUSINESS WIRE)–Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced the successful closing of a $20.4 million round of financing. This funding will enable Secretome to initiate clinical trials for its lead asset, STM-01, and further advance its innovative pipeline. “We are grateful […]



